Domača stran500660 • BOM
add
GlaxoSmithKline Pharmaceuticals Ltd
Prejšnji trg. dan.
2043,35 ₹
Dnevni razpon
2030,00 ₹ - 2066,80 ₹
Letni razpon
1825,05 ₹ - 3087,95 ₹
Tržna kapitalizacija
344,06 mrd. INR
Povprečni obseg
2,91 tis.
Razm. P/E
51,30
Dividendna donosnost
1,58 %
Primarna borza
NSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(INR) | sep. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 10,11 mrd. | 5,62 % |
Stroški poslovanja | 3,21 mrd. | −2,94 % |
Čisti dohodek | 2,52 mrd. | 16,09 % |
Čista dobičkovnost prihodkov | 24,98 | 9,90 % |
Earnings per share | — | — |
EBITDA | 3,21 mrd. | 11,39 % |
Efektivna davčna stopnja | 26,56 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(INR) | sep. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 21,11 mrd. | 31,49 % |
Skupna sredstva | 37,46 mrd. | 14,55 % |
Skupne obveznosti | 20,73 mrd. | 19,80 % |
Celoten lastniški kapital | 16,73 mrd. | — |
Shares outstanding | 172,12 mio. | — |
Razmerje P/B | 21,03 | — |
Donosnost sredstev | — | — |
Donosnost kapitala | 43,75 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(INR) | sep. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 2,52 mrd. | 16,09 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Datum ustanovitve
13. nov. 1924
Spletno mesto
Zaposleni
3.211